Health News Archive - January 28, 2009
A blood vessel disorder that can cause fatal hemorrhagic strokes, seizures or paralysis in mice can be treated with statin drugs, U.S. researchers have found.
DAVOS, Switzerland, Jan.
BIRMINGHAM, England, January 28 /PRNewswire/ -- The Binding Site Limited ("The Binding Site" or the "Company"), a privately-owned specialist U.K. diagnostics company, today announces the publication of the first international guidelines recommending first-line use of Freelite(TM) in the diagnosis and management of multiple myeloma, a cancer of cells in the bone marrow, and related plasma cell disorders. The guidelines were written on behalf of the International Myeloma Working Group ("IMWG"), led by Dr.
VALLEY COTTAGE, N.Y., Jan. 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd.
VALLEY COTTAGE, N.Y., Jan. 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTL) today announced an update to its December 8, 2008 press release regarding the Company's activities in seeking to acquire potential assets or to identify a company to merge into or with XTL.
LONDON, Jan. 28 /PRNewswire/ -- Limited purchasing power, combined with the lack of trained sonologists, has hampered growth in the ultrasound market in recent years. To compete with low-cost manufacturers, most vendors have started targeting the mid-range and low-end market segments.
ANTHEM, Ariz., Jan. 28 /PRNewswire-FirstCall/ -- Prime Companies, Inc.
INDIANAPOLIS, Jan. 28 /PRNewswire-FirstCall/ -- WellPoint, Inc. (NYSE: WLP) today announced that fourth quarter 2008 net income was $331.4 million, or $0.65 per share, including net realized investment losses of $350.5 million after-tax, or $0.69 per share.
MINNEAPOLIS, Jan. 28 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) announced today that it will release financial results for the third fiscal quarter ended December 31, 2008, at the market close on Tuesday, February 3, 2009.